CA 15.3 as a signal of undetectable breast cancer metastases in a follow-up period of 4 years.
Pizzichetta
M
M
Bogni
A
A
Seregni
E
E
Maffioli
L
L
de Jager
E
E
Costa
A
A
Bombardieri
E
E
D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D014408:Biomarkers, Tumor / Q000097:blood / Q000276:immunology; D001943:Breast Neoplasms / Q000097:blood / Q000276:immunology* / Q000556:secondary; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000276:immunology; D009378:Neoplasms, Multiple Primary / Q000097:blood / Q000276:immunology; D013997:Time Factors
D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor